Market Closed -
Hong Kong S.E.
09:08:06 30/04/2024 BST
|
5-day change
|
1st Jan Change
|
13.74
HKD
|
-1.58%
|
|
+5.86%
|
-53.58%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
114,126
|
353,422
|
318,544
|
223,341
|
113,607
|
53,754
|
-
|
-
|
Enterprise Value (EV)
1 |
109,822
|
348,931
|
312,303
|
219,728
|
108,159
|
46,746
|
45,689
|
43,294
|
P/E ratio
|
116
x
|
216
x
|
97.9
x
|
52.3
x
|
34.9
x
|
14.3
x
|
11.2
x
|
10.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
28.6
x
|
63
x
|
31
x
|
14.6
x
|
6.67
x
|
2.94
x
|
2.44
x
|
2.2
x
|
EV / Revenue
|
27.6
x
|
62.2
x
|
30.4
x
|
14.4
x
|
6.35
x
|
2.56
x
|
2.07
x
|
1.77
x
|
EV / EBITDA
|
65.7
x
|
142
x
|
68
x
|
32
x
|
15.5
x
|
7.29
x
|
5.79
x
|
5.07
x
|
EV / FCF
|
-54.8
x
|
-83.5
x
|
-101
x
|
-673
x
|
-
|
274
x
|
20.1
x
|
21.2
x
|
FCF Yield
|
-1.82%
|
-1.2%
|
-0.99%
|
-0.15%
|
-
|
0.36%
|
4.98%
|
4.73%
|
Price to Book
|
8.93
x
|
17.2
x
|
10.3
x
|
6.37
x
|
2.9
x
|
1.21
x
|
1.07
x
|
0.98
x
|
Nbr of stocks (in thousands)
|
3,883,578
|
4,084,763
|
4,224,123
|
4,225,262
|
4,222,732
|
4,162,831
|
-
|
-
|
Reference price
2 |
29.39
|
86.52
|
75.41
|
52.86
|
26.90
|
12.91
|
12.91
|
12.91
|
Announcement Date
|
26/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
26/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,984
|
5,612
|
10,290
|
15,269
|
17,034
|
18,280
|
22,036
|
24,399
|
EBITDA
1 |
1,671
|
2,464
|
4,590
|
6,857
|
6,993
|
6,413
|
7,892
|
8,546
|
EBIT
1 |
1,156
|
2,008
|
3,327
|
4,609
|
4,253
|
4,904
|
6,125
|
6,880
|
Operating Margin
|
29.02%
|
35.79%
|
32.33%
|
30.18%
|
24.97%
|
26.83%
|
27.79%
|
28.2%
|
Earnings before Tax (EBT)
1 |
1,127
|
1,966
|
3,993
|
5,358
|
4,174
|
4,749
|
6,023
|
6,655
|
Net income
1 |
1,010
|
1,689
|
3,388
|
4,420
|
3,400
|
3,919
|
4,987
|
5,503
|
Net margin
|
25.36%
|
30.09%
|
32.93%
|
28.95%
|
19.96%
|
21.44%
|
22.63%
|
22.56%
|
EPS
2 |
0.2533
|
0.4000
|
0.7700
|
1.010
|
0.7700
|
0.9044
|
1.154
|
1.281
|
Free Cash Flow
1 |
-2,003
|
-4,178
|
-3,106
|
-326.7
|
-
|
170.5
|
2,276
|
2,046
|
FCF margin
|
-50.27%
|
-74.44%
|
-30.19%
|
-2.14%
|
-
|
0.93%
|
10.33%
|
8.38%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
2.66%
|
28.83%
|
23.94%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
4.35%
|
45.63%
|
37.17%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
26/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
1,944
|
3,668
|
4,407
|
5,883
|
7,206
|
8,062
|
8,492
|
8,542
|
8,016
|
10,047
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
1,773
|
1,553
|
2,484
|
2,054
|
2,434
|
1,819
|
2,108
|
2,583
|
Operating Margin
|
-
|
-
|
40.24%
|
26.4%
|
34.47%
|
25.47%
|
28.66%
|
21.29%
|
26.3%
|
25.71%
|
Earnings before Tax (EBT)
|
-
|
1,261
|
-
|
-
|
-
|
2,428
|
2,529
|
1,645
|
-
|
-
|
Net income
|
-
|
952.8
|
-
|
1,546
|
-
|
1,885
|
2,267
|
1,133
|
-
|
-
|
Net margin
|
-
|
25.97%
|
-
|
26.28%
|
-
|
23.38%
|
26.69%
|
13.26%
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
0.5200
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/09/20
|
23/03/21
|
23/08/21
|
22/03/22
|
17/08/22
|
22/03/23
|
23/08/23
|
26/03/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
4,304
|
4,491
|
6,241
|
3,612
|
5,448
|
7,008
|
8,065
|
10,460
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2,003
|
-4,178
|
-3,106
|
-327
|
-
|
171
|
2,276
|
2,046
|
ROE (net income / shareholders' equity)
|
11.6%
|
10.1%
|
12.8%
|
13.1%
|
9.02%
|
9.06%
|
10.4%
|
10.3%
|
ROA (Net income/ Total Assets)
|
8.93%
|
7.25%
|
9.28%
|
9.45%
|
6.41%
|
6.9%
|
8.2%
|
8.09%
|
Assets
1 |
11,317
|
23,283
|
36,498
|
46,798
|
53,070
|
56,803
|
60,819
|
68,035
|
Book Value Per Share
2 |
3.290
|
5.030
|
7.300
|
8.290
|
9.270
|
10.70
|
12.00
|
13.20
|
Cash Flow per Share
2 |
0.3000
|
0.4400
|
0.7700
|
1.270
|
-
|
1.580
|
1.760
|
1.830
|
Capex
1 |
3,211
|
6,025
|
6,508
|
5,868
|
-
|
5,306
|
4,589
|
3,989
|
Capex / Sales
|
80.59%
|
107.35%
|
63.24%
|
38.43%
|
-
|
29.03%
|
20.82%
|
16.35%
|
Announcement Date
|
26/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
26/03/24
|
-
|
-
|
-
|
Last Close Price
12.91
CNY Average target price
26.4
CNY Spread / Average Target +104.45% Consensus |
1st Jan change
|
Capi.
|
---|
| -53.58% | 7.42B | | -2.94% | 102B | | +1.86% | 96.29B | | +2.42% | 22.18B | | -15.21% | 21.2B | | -9.07% | 18.31B | | -39.98% | 17.38B | | -14.45% | 16.36B | | +5.52% | 13.97B | | +31.71% | 12.17B |
Bio Therapeutic Drugs
|